{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:54:07Z","timestamp":1791255247585,"version":"4.1.0"},"reference-count":128,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Cyclodextrins, oligosaccharides linked in a circular arrangement around a central cavity, are used extensively in the pharmaceutical industry to improve drug delivery. Their usefulness depends on their capacity to form a drug inclusion, or host\u2013guest, complex within the cavity. In an attempt to improve the delivery of the widely used neuromuscular blocking drug (NMBD) rocuronium, a rocuronium inclusion complex was formed with a chemically modified \u03b3\u2010cyclodextrin. The high binding affinity and specificity of the modified carrier (named sugammadex) for rocuronium (and other aminosteroid NMBDs) led to its use in anaesthesia as an innovative and useful agent for rapid reversal of rocuronium\u2010induced neuromuscular block by sequestering the drug as an inclusion complex. This, in turn, led to the suggestion that sugammadex might be useful to remove the NMBD from the circulation of patients experiencing rocuronium\u2010induced anaphylaxis, a suggestion subsequently supported in case reports where traditional treatment had failed. Successful resuscitations suggested that sugammadex might be a valuable new treatment for such intractable cases but, given the inappropriateness of clinical trials, confirmation or refutation will have to await the slow accumulation of results of individual case reports. Important questions related to antibody accessibility of drug allergenic structures on the rocuronium\u2013sugammadex inclusion complex, and the competition between sugammadex and IgE antibodies (both free and cell bound) for rocuronium, also remain and can be investigated <jats:italic>in vitro<\/jats:italic>. The sugammadex findings indicate that the use of carrier molecules such as the cyclodextrins to improve drug delivery will sometimes give rise to changed immunologic and allergenic behaviour of some drugs and this will have to be taken into account in preclinical drug safety assessments of drug\u2013carrier complexes. The possibility of encapsulating and removing other allergenic drugs, e.g., penicillins and cephalosporins, in cases of difficult\u2010to\u2010reverse anaphylaxis to these drugs is discussed.<\/jats:p><jats:p>\n            <jats:italic>Cite this as<\/jats:italic>: B. A. Baldo, N. J. McDonnell and N. H. Pham, <jats:italic>Clinical &amp; Experimental Allergy<\/jats:italic>, 2011 (41) 1663\u20131678.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2011.03805.x","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T05:56:29Z","timestamp":1310018189000},"page":"1663-1678","source":"Crossref","is-referenced-by-count":43,"title":["Drug\u2010specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy"],"prefix":"10.1111","volume":"41","author":[{"given":"B. A.","family":"Baldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"435","article-title":"Sur la transformation de la fecule en dextrine par le ferment butyrique","volume":"112","author":"Villiers A.","year":"1891","journal-title":"Compt Rend Fr Acad Sci"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cber.19360690606"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/cber.19380710809"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-015-7797-7"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-66842-5"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr970022c"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02067497"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01265a091"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.198003441"},{"key":"e_1_2_8_11_2","first-page":"245","article-title":"\u03b3\u2010Cyclodextrin","volume":"77","author":"Li Z","year":"2007","journal-title":"a review on enzymatic production and applications"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01091a001"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-49192-4"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr9700181"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.199408031"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr960133w"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr970012b"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr960371r"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr970015o"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr970019t"},{"key":"e_1_2_8_21_2","first-page":"188","article-title":"Bildung kristallisierter Polysaccharide (Dextrine) aus St\u00e4rkekleister durch Microben","volume":"29","author":"Schardinger F.","year":"1911","journal-title":"Zentralbl Bakteriol Parasitenk Abt II"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1351\/pac200476101825"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1208\/pt060243"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014520830813"},{"key":"e_1_2_8_25_2","first-page":"57","volume-title":"Comprehensive supramolecular chemistry; Vol. 3, Cyclodextrins","author":"Jicsinszky L","year":"1996"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.10.044"},{"key":"e_1_2_8_27_2","first-page":"1806","article-title":"Cyclodextrin\u2010derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide","volume":"45","author":"Adams JM","year":"2002","journal-title":"synthesis and structure-activity relationships"},{"key":"e_1_2_8_28_2","first-page":"347","article-title":"Drug\u2010specific cyclodextrins","volume":"28","author":"Zhang M\u2010Q.","year":"2003","journal-title":"the future of rapid neuromuscular block reversal?"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrc.1008"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(02)00026-3"},{"key":"e_1_2_8_31_2","first-page":"266","article-title":"A novel concept of reversing neuromuscular block","volume":"41","author":"Bom A","year":"2002","journal-title":"chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrc.1083"},{"key":"e_1_2_8_33_2","first-page":"37","article-title":"Sugammadex","volume":"2","author":"Naguib M","year":"2009","journal-title":"a novel selective relaxant binding agent"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200309000-00018"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200510000-00007"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei314"},{"key":"e_1_2_8_37_2","first-page":"667","article-title":"Reversal of rocuronium\u2010induced neuromuscular block by the selective relaxant binding agent sugammadex","volume":"104","author":"Sorgenfrei IF","year":"2006","journal-title":"a dose-finding and safety study"},{"key":"e_1_2_8_38_2","first-page":"239","article-title":"Reversal of rocuronium\u2010induced (1.2\u2003mg\/kg) profound neuromuscular block by sugammadex","volume":"107","author":"de Boer HD","year":"2007","journal-title":"a multicenter, dose-finding and safety study"},{"key":"e_1_2_8_39_2","first-page":"1946","article-title":"Liquid chromatography\/mass spectrometric bioanalysis of a modified \u03b3\u2010cyclodextrin (Org 25969) and rocuronium bromide (Org 9426) in guinea pig plasma and urine","volume":"16","author":"Epemolu O","year":"2002","journal-title":"its application to determine the plasma pharmokinetics of Org 25969"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200111001-00037"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S2757"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael013"},{"key":"e_1_2_8_43_2","first-page":"575","article-title":"Sugammadex","volume":"104","author":"Naguib M.","year":"2007","journal-title":"another milestone in clinical neuromuscular block"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198306000-00003"},{"key":"e_1_2_8_45_2","first-page":"263","article-title":"Anaphylaxis during anaesthesia","volume":"11","author":"Fisher MM","year":"1994","journal-title":"current aspects of diagnosis and prevention"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/87.4.549"},{"key":"e_1_2_8_47_2","first-page":"471","article-title":"Anaphylaxis during anaesthesia","volume":"62","author":"Ebo DG","year":"2007","journal-title":"a diagnostic approach"},{"key":"e_1_2_8_48_2","first-page":"325","article-title":"On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs","volume":"39","author":"Baldo BA","year":"2009","journal-title":"an immunochemical perspective"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05733.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2007.01313.x"},{"key":"e_1_2_8_51_2","first-page":"325","article-title":"Anaphylaxis during induction of general anesthesia","volume":"86","author":"Moscicki RA","year":"1990","journal-title":"subsequent evaluation and management"},{"key":"e_1_2_8_52_2","first-page":"477","article-title":"The diagnosis and management of anaphylaxis practice parameter","volume":"126","author":"Lieberman P","year":"2010","journal-title":"2010 update"},{"key":"e_1_2_8_53_2","first-page":"796","article-title":"Epidemiologie des reactions anaphylactoides peranesthesiques","volume":"18","author":"Laxenaire MC.","year":"1999","journal-title":"quatrieme enquete multicentrique (juillet 1994\u2013decembre 1996)"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(05)81016-0"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004311-198511000-00010"},{"key":"e_1_2_8_56_2","first-page":"329","article-title":"Anaphylactoid reactions during anaesthesia","volume":"40","author":"Galletly DC","year":"1985","journal-title":"seven years' experience of intradermal testing"},{"key":"e_1_2_8_57_2","first-page":"55","article-title":"Cross reactivity of rocuronium with other neuromuscular blocking agents","volume":"11","author":"Laxenaire MC","year":"1995","journal-title":"Eur J Anaesthesiol"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/59.6.690"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90006-1"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427060-00004"},{"key":"e_1_2_8_61_2","first-page":"745","article-title":"Anaphylaxis to muscle relaxants","volume":"82","author":"Moneret\u2010Vautrin DA","year":"1988","journal-title":"cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases"},{"key":"e_1_2_8_62_2","first-page":"211","article-title":"Anaphylaxis to muscle relaxants","volume":"8","author":"Fisher MM.","year":"1980","journal-title":"cross sensitivity between relaxants"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/306262a0"},{"key":"e_1_2_8_64_2","first-page":"1393","article-title":"Anaphylaxis to muscle relaxant drugs","volume":"20","author":"Baldo BA","year":"1983","journal-title":"cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X8301100302"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92390-0"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(85)90087-0"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/57.11.1073"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(05)81022-6"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(05)81027-5"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706253162603"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90062-K"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/69.6.611"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/80.1.26"},{"key":"e_1_2_8_75_2","first-page":"167","article-title":"Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs","volume":"28","author":"Fisher MM","year":"2000","journal-title":"the value of morphine for the detection of IgE antibodies in allergic subjects"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03404.x"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(90)90127-L"},{"key":"e_1_2_8_78_2","first-page":"220","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Taylor P.","year":"1980"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00933.x"},{"issue":"1","key":"e_1_2_8_80_2","first-page":"7s","article-title":"Clinical practice guidelines","volume":"21","author":"Societe Francaises d'Anesthesie et de Reanimation.","year":"2002","journal-title":"reducing the risk of anaphylaxis during anaesthesia"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(84)80150-1"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0750-7658(85)80209-4"},{"key":"e_1_2_8_83_2","first-page":"678","article-title":"Rocuronium","volume":"86","author":"Rose M","year":"2001","journal-title":"high risk for anaphylaxis?"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2001.451001.x"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2001.451004.x"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200309000-00007"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeh203"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.6.844"},{"key":"e_1_2_8_89_2","first-page":"522","article-title":"Incidence of UK reactions involving rocuronium may simply reflect market use","volume":"87","author":"Watkins J.","year":"2001","journal-title":"Br J Anaesth"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000175213.87556.D8"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06178.x"},{"key":"e_1_2_8_92_2","first-page":"89","article-title":"Mitigation of rocuronium\u2010induced anaphylaxis by sugammadex","volume":"65","author":"Jones PM","year":"2010","journal-title":"the great unknown"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq366"},{"key":"e_1_2_8_94_2","unstructured":"PedersenNA FindsenL OlsenKS.Should sugammadex be used for the treatment of anaphylaxis induced by rocuronium? American Society of Anesthesiologists 2010 Meeting Abstracts Neuromuscular transmission abstract number A539. Available athttp:\/\/www.asaabstracts.com(accessed 9 March 2011)."},{"key":"e_1_2_8_95_2","unstructured":"LeysenJ BridtsCH De ClerckLS EboDG.Rocuronium\u2010induced anaphylaxis can probably not be mitigated by sugammadex: evidence from an in vitro experiment. Reply to Jones and Turkstra see ref. 96. Available athttp:\/\/www.respond2articles.com\/ANA\/forums\/28503\/ShowForum.aspx(accessed 9 March 2011)."},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06177_2.x"},{"key":"e_1_2_8_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-635504-8.50008-0"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-69088-4_16"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(90)90094-G"},{"key":"e_1_2_8_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-001-0093-4"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1039\/b517275f"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.2174\/156720108783330998"},{"key":"e_1_2_8_103_2","doi-asserted-by":"publisher","DOI":"10.2174\/157016308784746328"},{"key":"e_1_2_8_104_2","doi-asserted-by":"publisher","DOI":"10.1211\/002235702649"},{"key":"e_1_2_8_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.02.006"},{"key":"e_1_2_8_106_2","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.0808-05"},{"key":"e_1_2_8_107_2","first-page":"556","article-title":"Cyclodextrins","volume":"14","author":"Stella VJ","year":"1997","journal-title":"their future in drug formulation and delivery"},{"key":"e_1_2_8_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00052-0"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.1021\/js960075u"},{"key":"e_1_2_8_110_2","doi-asserted-by":"publisher","DOI":"10.1027\/0838-1925.12.5.206"},{"key":"e_1_2_8_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1996.tb00502.x"},{"key":"e_1_2_8_112_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00887.x"},{"key":"e_1_2_8_113_2","first-page":"1644","article-title":"\u03b2\u2010Lactam allergenic determinants","volume":"32","author":"Zhao Z","year":"2002","journal-title":"fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin"},{"key":"e_1_2_8_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(90)90151-O"},{"key":"e_1_2_8_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198910000-00003"},{"key":"e_1_2_8_116_2","first-page":"1347","article-title":"Drugs as allergens","volume":"25","author":"Harle DG","year":"1988","journal-title":"detection and combining site specificities of IgE antibodies to sulfamethoxazole"},{"key":"e_1_2_8_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1990.tb03139.x"},{"key":"e_1_2_8_118_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.300080302"},{"key":"e_1_2_8_119_2","first-page":"287","article-title":"\u00df\u2010Lactam drug allergens","volume":"9","author":"Pham NH","year":"1996","journal-title":"fine structural recognition patterns of cephalosporin-reactive IgE antibodies"},{"key":"e_1_2_8_120_2","first-page":"11","volume-title":"Molecular approaches to the study of allergens. Monographs in allergy","author":"Baldo BA","year":"1990"},{"key":"e_1_2_8_121_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00042a001"},{"key":"e_1_2_8_122_2","volume-title":"The specificity of serological reactions","author":"Landsteiner K.","year":"1962"},{"key":"e_1_2_8_123_2","unstructured":"Bridion 100\u2003mg\/mL solution for injection Summary of Product Characteristics. Available athttp:\/\/www.medicines.org.uk\/EMC\/medicine\/21299\/SPC\/Bridion(accessed 9 March 2011)."},{"key":"e_1_2_8_124_2","first-page":"867","article-title":"Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96\u2003mg\/kg) in healthy adult subjects","volume":"30","author":"Peeters PAM","year":"2010","journal-title":"a randomized, double blind, crossover, placebo-controlled, single-centre study"},{"key":"e_1_2_8_125_2","unstructured":"FDA rejects Schering\u2010Plough's anaesthetic drug sugammadex NDA. Available athttp:\/\/www.medicalnewstoday.com\/articles\/117156.php(accessed 9 March 2011)."},{"key":"e_1_2_8_126_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2010.06611.x"},{"key":"e_1_2_8_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(04)03276-3"},{"key":"e_1_2_8_128_2","first-page":"2238","article-title":"Dendrimers","volume":"3","author":"Semwal R","year":"2010","journal-title":"a novel approach for drug targeting"},{"key":"e_1_2_8_129_2","doi-asserted-by":"publisher","DOI":"10.2240\/azojono0111"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2011.03805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2011.03805.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:54:52Z","timestamp":1695516892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2011.03805.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":128,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1111\/j.1365-2222.2011.03805.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2011.03805.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}